Psychiatry & Neurology Doctors in Brewster, NY Accepting Medicare

6 Psychiatry & Neurology doctors found. Showing 1 - 6

Jacob Calvin Nafziger, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 1620 Route 22, Suite 203, Brewster, NY 10509 Phone: 845-278-2500

Dr. Leo Jan Bastiaens, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 1620 Route 22 Ste 203, Brewster, NY 10509 Phone: 845-278-2500    Fax: 844-454-5096

Waldimar P Alarkon, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 1620 Route 22, Brewster, NY 10509 Phone: 845-278-2500

Dr. Elizabeth V. Getter, MD Psychiatry & Neurology - Psychiatry Medicare: Medicare Enrolled Practice Location: 64 Vails Lake Shore Dr, Brewster, NY 10509 Phone: 212-677-0075    Fax: 364-202-9147

Agnes Juhasz, MD Psychiatry & Neurology - Psychiatry Medicare: Not Enrolled in Medicare Practice Location: 400 Doansburg Rd, Brewster, NY 10509 Phone: 845-279-2995

Dr. Andrew Looker, M.D. Psychiatry & Neurology - Child & Adolescent Psychiatry Medicare: Medicare Enrolled Practice Location: 12 Main St # 215, Brewster, NY 10509 Phone: 212-369-1398

News Archive

Prostate cancer - TRAIL is worth a trial

One of the human body's protective mechanisms initiated by the TRAIL protein is massively altered in prostate cancer cells - yet the same protein seems to improve the survival prospects of patients. These outstanding results of a cooperative venture between the Clinical Program on Urological Tumours at the Medical University of Vienna and Harvard Medical School, USA, have just been published. They show that the TRAIL protein opens up the prospect to a more accurate prediction of the disease's course, as well as the opportunity to identify a new intervention point for innovative therapies in advanced prostate cancer.

H. D. Smith becomes primary supplier of pharmaceutical products for NAPPSA pharmacies

NAPPSA, a pharmacy buying group advancing the growing buying power of the Nigerian-owned independent retailers, today announced a new three-year prime vendor agreement with H. D. Smith, a leading national pharmaceutical wholesaler.

Sunwin and WILD Flavors complete FDA's GRAS status for their stevia extracts

Sunwin International Neutraceuticals, Inc. ("Sunwin") (OTCBB: SUWN) - a worldwide supplier of all-natural, zero-calorie stevia, and WILD Flavors, Inc. ("WILD Flavors") - one of the largest, privately-owned suppliers of natural and health-enhancing ingredients, flavors, colors, and innovative product concepts to the food and beverage industry, have completed the process for U.S. Food and Drug Administration ("FDA") self-affirmed GRAS status for stevia extracts produced by Sunwin and sold worldwide.

Higher ‘mutational burden' of tumors predicts success rate with cancer immunotherapies

The "mutational burden," or the number of mutations present in a tumor's DNA, is a good predictor of whether that cancer type will respond to a class of cancer immunotherapy drugs known as checkpoint inhibitors, a new study led by Johns Hopkins Kimmel Cancer Center researchers shows.

Read more Medical News

› Verified 3 days ago